NCT07116564 Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries
| NCT ID | NCT07116564 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Aga Khan University |
| Condition | ERAS |
| Study Type | INTERVENTIONAL |
| Enrollment | 98 participants |
| Start Date | 2025-08-20 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 98 participants in total. It began in 2025-08-20 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries
Eligibility Criteria
Inclusion Criteria: * ASA physical status I, II, and III * Patients scheduled for elective laparoscopic gynecological surgeries Exclusion Criteria: * Refusal to participate * History of allergy or contraindication to study drugs * Patients in which procedure converted to open surgery * Diagnostic laparoscopic procedures * Patients with a history of severe anxiety or depression
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07116564 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 60 Years, studying ERAS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07116564 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07116564 currently recruiting?
Yes, NCT07116564 is actively recruiting participants. Contact the research team at sarfraz.siddiqui@aku.edu for enrollment information.
Where is the NCT07116564 trial being conducted?
This trial is being conducted at Karachi, Pakistan.
Who is sponsoring the NCT07116564 clinical trial?
NCT07116564 is sponsored by Aga Khan University. The trial plans to enroll 98 participants.